摘要
中医药国际化是我国中医药发展的战略目标之一,已被纳入国家战略并作为“一带一路”发展规划的重要组成部分。中药作为中医药发展的基础和前提,其国际化程度直接影响着中医药国际化进程。ISO国际标准化组织是一个由国家标准化机构组成的世界范围的联合会,其制定的标准在世界范围内对经济、贸易及交流合作具有重大影响。该文在简要概述国际标准化组织/中医药技术委员会(ISO/TC 249)的基础上,阐述了中药国际标准制定的必要性,分析了中药国际标准制定的现状,最后针对中药国际标准制定面临的挑战,提出我国中药国际标准制定的发展策略:以国际市场需求为导向,做好顶层设计;强化标准质量的提升,加速推进国内高质量标准转化为国际标准;充分发挥企业在标准制定中的积极作用;大力培养复合型中药国际标准化人才;加强国际合作等。对中药国际标准制定的问题思考与经验对今后如何科学、高效、合理地制定高质量中药国际标准具有重要指导意义。
The internationalization of traditional Chinese medicine(TCM)is one of the strategic development objectives in China,which has been incorporated into the national strategy as an important part of the Belt and Road Initiative development strategy.As the basis and prerequisite of TCM development,Chinese materia medica(CMM)has a direct impact on the internationalization of TCM.The International Organization for Standardization(ISO)is a global organization composed of national standardization bodies,and the ISO standards impact the world′s economy,trade,communication and cooperation.Based on a brief introduction to ISO/Traditional Chinese Medicine Technical Committee(ISO/TC 249),this study elaborates the necessity of establishing ISO standards for CMM and analyzes the current status and challenges faced by the formulation of international standards for CMM.Finally,this study puts forward the development strategy of international standards for CMM.Specifically,efforts should be made to develop top-level design with international market demands as the guidance and improve the quality of standards to accelerate the transformation of domestic high-quality standards into international standards.Moreover,measures should be taken to give full play to the positive role of enterprises in the formulation of standards,vigorously cultivate compound talents for international standardization of TCM,and constantly strengthen international cooperation.The experience and thinking are of guiding significance for the scientific,efficient and reasonable formulation of high-quality ISO standards for CMM in the future.
作者
何雅莉
郭兰萍
葛阳
谭勇
康传志
徐晓婷
吕朝耕
杨龙会
袁庆军
HE Ya-li;GUO Lan-ping;GE Yang;TAN Yong;KANG Chuan-zhi;XU Xiao-ting;LYU Chao-geng;YANG Long-hui;YUAN Qing-jun(State Key Laboratory Breeding Base of Dao-di Herbs,National Resource Center for Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of TCM International Standardization,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China)
出处
《中国中药杂志》
CAS
CSCD
北大核心
2022年第13期3675-3680,共6页
China Journal of Chinese Materia Medica
基金
国家重点研发计划项目(2017YFC1703700-04)
中央本级重大增减支项目(2060302)。
关键词
中药
国际标准
现状
发展策略
Chinese materia medica(CMM)
ISO standard
current status
development strategy